Washington imposes steep future tariffs on generic drugs
Tap title to read story
WASHINGTON — President Donald Trump announced on July 21, 2026, that the United States will apply a 100 percent tariff on all imported generic drugs beginning in August 2028, following a two-year transition period with a zero tariff. After one year at 100 percent, the levy is scheduled to rise to 200 percent. The administration says the policy is intended to reshore generic drug manufacturing, which supplies most prescriptions in the United States, by encouraging companies to build domestic production facilities. The move expands an April 2026 Section 232 national security proclamation that had imposed tariffs on branded pharmaceuticals but initially exempted generics.
More context
Timeline
- April 2026 White House issues Section 232 proclamation
- April 2026 Tariffs target branded pharmaceuticals and ingredients
- April 2026 Generic drugs initially receive explicit exemption
- July 21, 2026 Trump announces generic drug tariff plan
- August 2028 Zero-tariff transition period scheduled to end
- August 2028 One hundred percent tariff to begin
- August 2029 Tariff planned to rise to two hundred percent
Why it matters
Your prescription costs could rise sharply. The new tariffs on imported generic drugs might make them pricier. If you rely on these for your health, start budgeting now. Check if your insurance covers potential price hikes.
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.
